According to the analyst firm Global Information, the demand for biologics and biosimilars is estimated to grow to more than $100 billion in 2015, continuing the double-digit growth rate seen in the last decade. As the industry continues to grow, alternative delivery methods are of increasing interest—particularly the topical delivery of large molecules.
Formulation for any topical pharmaceutical is a top priority—any misstep can affect the efficacy of the molecule. Biologics also have the additional consideration of achieving the right penetration to the target. Tergus, the leader in topical pharmaceutical formulation, development, analysis and testing, works with global companies and top universities and labs to create topical formulations for biologics.